These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 23067349)

  • 1. A pilot metabolic profiling study in serum of patients with chronic kidney disease based on (1) H-NMR-spectroscopy.
    Qi S; Ouyang X; Wang L; Peng W; Wen J; Dai Y
    Clin Transl Sci; 2012 Oct; 5(5):379-85. PubMed ID: 23067349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
    Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
    Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR-based serum metabolomics study reveals a innovative diagnostic model for missed abortion.
    Wu Z; Jin L; Zheng W; Zhang C; Zhang L; Chen Y; Guan J; Fei H
    Biochem Biophys Res Commun; 2018 Feb; 496(2):679-685. PubMed ID: 29353036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ¹H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus.
    Ouyang X; Dai Y; Wen JL; Wang LX
    Lupus; 2011 Nov; 20(13):1411-20. PubMed ID: 21976403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proton nuclear magnetic resonance-based metabonomics study of metabolic profiling in immunoglobulin a nephropathy.
    Sui W; Li L; Che W; Guimai Z; Chen J; Li W; Dai Y
    Clinics (Sao Paulo); 2012; 67(4):363-73. PubMed ID: 22522762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of nuclear magnetic resonance spectroscopy for the detection of metabolic disorders in patients with moderate kidney insufficiency.
    Mika A; Wojtowicz W; Ząbek A; Młynarz P; Chmielewski M; Sledzinski T; Stepnowski P
    J Pharm Biomed Anal; 2018 Feb; 149():1-8. PubMed ID: 29100025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H NMR-based metabolite profiling of plasma in a rat model of chronic kidney disease.
    Kim JA; Choi HJ; Kwon YK; Ryu DH; Kwon TH; Hwang GS
    PLoS One; 2014; 9(1):e85445. PubMed ID: 24465563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pilot Metabolic Profiling Study of Patients With Neonatal Jaundice and Response to Phototherapy.
    Cai A; Qi S; Su Z; Shen H; Yang Y; Cai W; Dai Y
    Clin Transl Sci; 2016 Aug; 9(4):216-20. PubMed ID: 27306191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of (1)h NMR spectroscopy-based metabolomics to sera of tuberculosis patients.
    Zhou A; Ni J; Xu Z; Wang Y; Lu S; Sha W; Karakousis PC; Yao YF
    J Proteome Res; 2013 Oct; 12(10):4642-9. PubMed ID: 23980697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic profile of secondary hyperparathyroidism in patients with chronic kidney disease stages 3-5 not receiving dialysis.
    Gan L; Wang L; Li W; Zhang Y; Xu B
    Front Endocrinol (Lausanne); 2024; 15():1406690. PubMed ID: 39027473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rule-Mining for the Early Prediction of Chronic Kidney Disease Based on Metabolomics and Multi-Source Data.
    Luck M; Bertho G; Bateson M; Karras A; Yartseva A; Thervet E; Damon C; Pallet N
    PLoS One; 2016; 11(11):e0166905. PubMed ID: 27861591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using nuclear magnetic resonance urine metabolomics to develop a prediction model of early stages of renal disease in subjects with type 2 diabetes.
    Lucio-Gutiérrez JR; Cordero-Pérez P; Farías-Navarro IC; Tijerina-Marquez R; Sánchez-Martínez C; Ávila-Velázquez JL; García-Hernández PA; Náñez-Terreros H; Coello-Bonilla J; Pérez-Trujillo M; Parella T; Torres-González L; Waksman-Minsky NH; Saucedo AL
    J Pharm Biomed Anal; 2022 Sep; 219():114885. PubMed ID: 35779355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ¹H NMR-based metabolic profiling of human rectal cancer tissue.
    Wang H; Wang L; Zhang H; Deng P; Chen J; Zhou B; Hu J; Zou J; Lu W; Xiang P; Wu T; Shao X; Li Y; Zhou Z; Zhao YL
    Mol Cancer; 2013 Oct; 12(1):121. PubMed ID: 24138801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear Magnetic Resonance-Based Metabolomics Approach Revealed the Intervention Effect of Using Complementary and Alternative Medicine (CAM) by CKD Patients.
    Gupta N; Yadav DK; Gautam S; Kumar A; Kumar D; Prasad N
    ACS Omega; 2023 Feb; 8(8):7722-7737. PubMed ID: 36872986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic profiling of kidney and urine in rats with lithium-induced nephrogenic diabetes insipidus by (1)H-NMR-based metabonomics.
    Hwang GS; Yang JY; Ryu DH; Kwon TH
    Am J Physiol Renal Physiol; 2010 Feb; 298(2):F461-70. PubMed ID: 19923409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
    Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
    [No Abstract]   [Full Text] [Related]  

  • 17. Untargeted plasma
    Fonseca RID; Menezes LRA; Santana-Filho AP; Schiefer EM; Pecoits-Filho R; Stinghen AEM; Sassaki GL
    J Pharm Biomed Anal; 2023 May; 229():115339. PubMed ID: 36963247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in serum metabolites with the stage of chronic kidney disease: Comparison of diabetes and non-diabetes.
    Lee J; Choi JY; Kwon YK; Lee D; Jung HY; Ryu HM; Cho JH; Ryu DH; Kim YL; Hwang GS
    Clin Chim Acta; 2016 Aug; 459():123-131. PubMed ID: 27221201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted and untargeted serum NMR metabolomics to reveal initial kidney disease in diabetes mellitus.
    Lucio-Gutiérrez JR; Cordero-Pérez P; Ávila-Velázquez JL; Torres-González L; Farías-Navarro IC; Govea-Torres G; Sánchez-Martínez C; García-Hernández PA; Coello-Bonilla J; Pérez-Trujillo M; Parella T; Waksman-Minsky NH; Saucedo AL
    J Pharm Biomed Anal; 2024 Sep; 247():116240. PubMed ID: 38820837
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.